Measuring Symptom Similarity: Setting Standards for Accurate Rare Disease Diagnosis

🧬 Part of the Decoded Series: Technical Insights from 3billion

In rare disease diagnosis, every symptom matters—but not all tools measure them equally well.

Physicians often begin their diagnostic process with symptoms, while AI tools tend to focus on genes. Bridging these two worlds requires models that accurately understand and score symptom similarity.

But how can we be sure those models are doing their job?

Why was this technology needed?

Symptom similarity plays a critical role in diagnosing rare diseases.
While most genomic tools focus on interpreting variants, clinical diagnosis usually starts with symptoms. Physicians ask: “What disease best explains this symptom set?”
But genetic testing gives us a different language—variant-disease associations.

The real challenge?

There was no established way to evaluate how well different symptom similarity systems perform.
Multiple systems may offer “relevance scores,” but without a standardized benchmark, how can we tell which one truly aids diagnosis?

What problem does it solve?

This innovation started with a simple but essential question:

“How effective is our symptom similarity model in aiding accurate diagnoses?”

To answer this, 3billion developed a new patented system that evaluates the performance of symptom similarity algorithms.
It involves four key components:

1. Similarity Scoring
For each patient, it calculates similarity between patient symptoms and two types of disease sets:

2. Normalization & Adjustment
The raw similarity scores are normalized to remove biases and create consistent evaluation metrics.

3. Aggregate Evaluation
Adjusted similarity scores are aggregated across all patients to generate total scores for both variant-related and unrelated diseases.

4. Performance Verification
A truly effective model should give higher similarity scores for variant-related diseases. This system quantifies that gap, serving as a clear performance indicator.

Why it matters

• Establishes an objective standard
  Now, developers and clinicians can measure the quality of symptom-matching systems with quantitative benchmarks.
  
• Accelerates algorithm development
  With performance evaluation in place, researchers can optimize their models with clearer feedback loops.
  
• Improves clinical usability
  Hospitals and labs can select proven models for real-world use based on tested performance—not just intuition.
  

FAQ

Q. What is a symptom similarity model?
A tool that compares a patient’s symptoms against known symptom sets of diseases to calculate how closely they match—essential for rare disease diagnosis.

Q. Why do we need an evaluation system for it?
To ensure these tools actually help physicians, we need a standardized way to measure how well they distinguish relevant diseases from irrelevant ones.

Patent Source

📄 Full Patent Access
Read the full patent on KIPRIS(Korea Intellectual Property Rights Information Service)
Patent title: System and Method for Evaluating Performance of Symptom Similarity Measure Apparatus
Patent no.: 1020180136481

🧬 Want to see the impact in action?

---

About this series

Decoded is a technical storytelling series from 3billion that reveals the science behind our diagnostic technologies.
We break down the mathematical models and algorithmic innovations that enhance rare disease diagnostics—making the invisible, visible.